Peter Verhoeven (chairman Vasculitis NL) writes about FAIRVASC in the magazine (Vascuzine) of their Dutch patient organization. Please find both the Dutch and English versions here
You may also like
Application for a clinical RMD research methodology was approved by the EULAR research Committee on the 12th of MARCH 2024, for a total […]
One of the tasks of the POLVAS team was to organize and conduct a Hackathon which had 2 aims: 1) to analyse […]
The FAIRVASC consortium had a very active involvement at the 20th International Vasculitis and ANCA Workshop 03-06 April 2022, held in Dublin, […]
Within FAIRVASC Workpackage 2 (WP2) will capture the legal and ethical environment of each registry, patient perspectives on data sharing and re-use, […]